Markets controller Sebi decreased the timetables for discount of financial backers’ cash to four days if there should arise an occurrence of non receipt of least membership and the guarantor neglecting to get posting or exchanging authorization from the stock trades.
The timetables have been decreased subsequent to thinking about that Application Supported by Blocked Amount (ASBA) has been commanded for all candidates in broad daylight issues.
As a feature of the system, the application cash isn’t moved however just impeded in the financial backer’s record and is charged uniquely upon distribution. It is unblocked if there is no or part allocation.
Further, post presentation of Unified Payments Interface (UPI) instrument openly issues, delegates are dependable to remunerate financial backers for any postponement in unblocking of sums in the ASBA accounts surpassing four working days from the bid or issue shutting date.
In view of different counsels with the market members, it has been chosen to diminish the timetables for discount of the cash to the financial backers… to four days.
As of now, if there should arise an occurrence of non receipt of least membership, the guarantor is ordered to discount all the application cash inside 15 days from the conclusion of the issue. In the event that the guarantor neglects to acquire posting or exchanging consent from the stock trades where the protections were to be recorded, it should discount the whole cash got inside 7 days of receipt of implication from the trades dismissing the application.
These timetables have now been decreased to four days.
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
TATA Steel recaptured market capitalisation (market-cap) of Rs 1 trillion in Thursday’s intra-day exchange after the stock hit its most significant level since June 2008, on sound operational execution and assumption for development in the organization’s viewpoint. In the previous multi week, the stock has mobilized 16%, against 2.2 percent ascend in the S&P BSE Sensex.
TATA Steel Steel’s market-cap hit Rs 1-trillion (Rs 100,053 crore) after the stock hit a high of Rs 836.15, up 3% on the BSE in intra-day exchange today. the scrip was exchanging 2.6 percent higher at Rs 833 with the market-cap of Rs 99,682 crore, BSE information appeared.
Moody’s, on Wednesday, amended the point of view toward Tata Steel Ltd from “negative” to “stable” on the organization’s strong recuperation in tasks in the second from last quarter of current financial year (FY21). The worldwide rating organization attested the organization’s Ba2 corporate family appraising (CFR). The organization will support the improvement more than 12-year and a half, empowering its combined monetary measurements to recuperate to levels more proper for its Ba2 CFR, it said.
The rating activity additionally mirrors the organization’s proactive monetary administration in the midst of the [Covid-19] pandemic. It has freely expressed objective of paying off net obligation by in any event $1 billion every year and focusing on deleveraging over capital use.
In the previous a half year, the stock has zoomed 130%, when contrasted with 28% ascent in the S&P BSE Sensex. The recuperation in the worldwide and Indian economy has prompted sharp improvement in steel interest in India. The interests in framework and ongoing arrangement advancements, to drive monetary development, should drive steel interest in India.
Higher worldwide costs could drive trades higher in the close term as homegrown players may hope to clear their inventories with FY21 reaching a conclusion. In addition, adjustment in steel costs in the homegrown market and premium proposals in the global market has made fares more appealing.
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
Penny stocks are those that exchange at an extremely low cost, have exceptionally low market capitalization, are generally illiquid, and are normally recorded on a more modest trade. Penny stocks in the Indian securities exchange can have costs below Rs 50. These stocks are speculative in nature and are considered profoundly hazardous due to absence of liquidity, more modest number of investors, enormous bid-request spreads and restricted revelation from data.
Consequently, you could buy a significant measure of stock units from penny stock list with a small investment.
For what reason SHOULD WE INVEST in these companies ?
Organizations giving them may develop into an enormous association and yield higher than normal returns or tank in their underlying years, causing colossal misfortunes.
Given the scale at which the organizations offering such stocks work, they are inclined to immense dangers. These stocks intensely depend available conditions for development in their worth.
Company data: Given the way that organizations giving penny stocks are new companies, there exists a deficiency of data on their monetary sufficiency, past execution, development possibilities, and so forth People may wind up putting resources into them half-wittingly. In this manner, direct careful examination into the rundown of penny stocks in India prior to contributing.
Scam: Penny stock Scam are ordinary in global monetary history. Organizations and Operators buy a lot of penny stocks bringing about their expansion which draws in different financial backers to follow the publicity.
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities.
All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information,
Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed.
No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
Given link below : given on 26.03.2021 With in 4 Days Achieved First Target . Get Ready for Second Target also .
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
ABOUT COMPANY : Godfrey Phillips India is one of the largest FMCG companies in the country with many iconic cigarette brands like Four Square, Red & White, and Cavanders to its name. We also have an exclusive sourcing and supply agreement with Philip Morris International to manufacture and distribute the renowned Marlboro brand in India.
Godfrey Phillips India has expanded its product portfolio beyond cigarettes and tobacco and entered India’s highly competitive chewing products, mouth freshener, confectionery segment and retail. Pan Vilas pan masala, Pan Vilas Silver Dewz – a silver-coated Elaichi (cardamom seed) and Funda Goli candies are all manufactured by the Company at attractive price points. Our premium retail outlets 24Seven is already a brand to contend with.
Our brands are popular and we are a successful company because our people love what they do, are fully committed to our consumers and are a great team to work with. Godfrey Phillips India has been certified as a Great Place to Work by the Great Place to Work®️ Institute and ranked 29th on India’s Best Companies to Work For over the 37th ranking last year 2019.
Excellence and Quality is our mantra and reflected in the technology, processes and certifications of the manufacturing units.
The Cigarette manufacturing units located in Rabale and Guldhar have top brass technology partners like Philip Morris, G.D., Comas, SMC, Luwa, Forbes Marshall, Honeywell, Miebach, Nefab, Kaesar, and the Haulotte Group. Our units also have top certifications of ISO 9001, 5001, 14000 and OHSAS. The Guldhar factory is the first one in the tobacco industry to have a Social Accountability 8000 certification and best processes including Six Sigma, TQM, Haichi Ban, 5 S and Kaizen. The Chewing products facility at Ghaziabad has a technology tie up with the Swiss company, Buhler, ACG-Palm Glantt and Japan based FFS Topack. Along with processes like Six Sigma, 5 S, Kaizen and Lean Manufacturing, the Ghaziabad unit also boasts of certifications like ISO – 22000 & ISO- 14001.
Our facilities have been highly recognized for their commitment to quality, safety, and environment management and have multiple prestigious awards under their belt from various Government bodies, GMA, Greentech, ASSOCHAM and FICCI.
R & D : Godfrey Phillips India boasts of two state- of- art research and development facilities that employs some of India’s best scientists, cigarette designers, blenders and flavourists.
The Insight Tobaccocraft Institute is the first laboratory in the Indian tobacco industry to be accredited with an ISO 17025 certification, as well as recognition from the government’s Department of Science and Technology.
Our qualified blenders here, hailing from specialized fields of agricultural sciences, have mastered the art of tobacco selection and blending. Combining the traditional art of tobacco selection with advanced filtration technology and modern methods, we craft deeply flavorsome and satisfying smoking experiences. We are equipped to develop various cigarette blends matching the palette of customers across the globe, besides meeting the regulatory requirements of different parts of world. By being located alongside our production facilities, our R&D team can also combine synergies and create the best blends for domestic and international markets, based on customer needs.
In order to bring greater reliability to our analytical results, we also take part in initiatives such as the Asia Collaborative Study (ACS). Our participation each year, along with 58 other prominent cigarette companies of the world, such as PMI, BAT and JTI, helps cross calibrate our results with the best in the business. Our Z- scores, which determine the quality of analytical data, vis-à-vis the best in the world, have proven to be excellent year on year. The Insight Tobaccocraft Institute also makes blending and product development easy with its state-of-the-art, automated pilot plant, which is capable of processing and making sample cigarettes at a faster pace in relatively smaller quantities. Continuous improvement, reverse engineering, creating product differentiation, and innovation are the core strengths of the Insight Tobaccocraft Institute.
The Future Food Focus Institute was set up in late 2015 as a centre to develop and standardize Indian food products like Pan Masala and Mouth-fresheners as well as modern products like confectioneries and beverages in a modern scientific manner, and to lend expertise to group companies of Modi Enterprises and to vendors manufacturing products for Godfrey Phillips.
Food Focus also boasts of highly qualified personnel with a wide range of experience in development, scaling-up and testing of different types of food products, ranging from Pan Masalas and Chewing Tobacco to Savory Snacks, Confectionery, Mouth-fresheners, Tea and Beverages, Extruded Food and Dehydrated food products.
The Institute has two fully functional product development laboratories for development of various products , a flavor development laboratory and a pilot plant for scaling up products to the factory. The centre has analytical facilities for testing of food, comprising of a wet chemistry laboratory, an instrumental laboratory and a stability laboratory.
In Future Food Focus Institute products are conceived, created and tested in both sensorial and chemical aspects, so that we are able to provide innovative, best quality products for our consumers.
Godfrey Phillips India’s products are distinct. From cigarettes to chewing, confectionery and retail, all our products are outcomes of the innovative, performance driven, and high–quality mindset of our people. Our talented workforce infuses their expertise and energy in every product category, giving our brands an edge over others.
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
NOW Technically Very good Getting Ready for New 52 Weeks High Possible in Coming Days and Months from here on.
Best Price can be 1950 .
52 WEEKS HIGH /LOW : 2277/ 925 (27.03.2021) .
Target : 2400 to 3000 .
Time frame : 6 Months to 2 Years .
Study Purpose Only .
one of India’s leading animal healthcare companies and are the second largest poultry vaccine manufacturer in the country. Founded by Mr. Rajiv Gandhi, Hester began its journey in 1987. Over the years, it has transformed from a small proprietary trading business into Asia’s largest one-stop animal biological manufacturing facility.
We now have a strategic presence in over 30 countries, while focusing on key market needs in India, Nepal and Tanzania. We have also partnered with various organizations over the years including Bill & Melinda Gates Foundation, GALVmed, Golchha Organization, and our latest foray into the Egyptian market with Nova pharma, to name a few.
Headquartered in Ahmedabad, Gujarat, we operate through four broad verticals: Poultry Vaccines, Poultry Health Products, Animal Vaccines and Animal Health Products. Additionally, in an effort to provide our customers with end-to-end solutions, our services include seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.
We strongly believe the 4A principle: ‘Aware smallholder farmers can achieve great heights if Appropriate products and services are made Available to them at Affordable prices.
https://www.hester.in/
PRODUCTS :
ANIMAL HEALTH CARE
POULTRY HEALTH CARE
DIAGNOSTIC LABS
Very Consistent ROCE % FROM PAST 9 YEARS .
Ratios
Consolidated Figures in Rs. Crores / View Standalone
ROCE %
Mar 2011
Mar 2012
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
ROCE %
20%
20%
18%
15%
19%
20%
20%
27%
16%
Debtor Days
115
109
85
75
72
95
79
87
67
116
Inventory Turnover
0.41
0.64
0.47
0.91
0.81
1.13
0.96
0.93
0.63
Shareholding Pattern
Numbers in % .
Mar 2018
Jun 2018
Sep 2018
Dec 2018
Mar 2019
Jun 2019
Sep 2019
Dec 2019
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Promoters +
54.09
54.09
54.09
54.09
54.09
54.09
53.74
53.73
53.73
53.73
53.73
53.73
FIIs +
1.71
1.77
1.78
1.78
1.77
1.75
1.77
1.49
0.59
0.62
0.62
0.63
DIIs +
0.57
0.65
0.66
0.63
0.64
0.61
0.59
0.67
0.11
0.16
0.22
0.22
Government +
0.49
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Public +
43.13
43.49
43.47
43.50
43.50
43.54
43.90
44.11
45.56
45.48
45.42
45.42
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
As per Technical Charts its Clearly Indicating New 52 Weeks High it Might Crossed in Short Term Itself .
About Company : Controlled by the Arun Bharat Ram family, Kama Holdings also has business interests in education , real estate and investment through three wholly owned subsidiaries:
Shri Educare Limited
KAMA Realty (Delhi) Limited
SRF Transnational Holdings Limited
Shri Educare Limited (SEL) is an entity providing quality education, essentially by way of setting up schools (from nursery to class 12) and pre-schools, and undertaking education consultancy, in India and abroad. These schools are modeled on the pattern of The Shri Ram Schools, an initiative of SRF Foundation, the social wing of SRF Limited.
KAMA Realty (Delhi) Limited, inter-alia owns commercial properties in Gurgaon and Mumbai.
SRF Transnational Holdings Limited is a registered NBFC engaged in the business of investment in securities of other companies.
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
READY FOR NEW 52 WEEKS HIGH AGAIN : GET READY . Initially given at 780 Now at New 52 Weeks high @ 885 Touched Recently . Acpecting Revised Targets of Rs. 900 to 940 Possible in Coming Days Further Also .
Time Frame : 5 days
Here is A link Given Below .
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
With a US $6 billion asset base and US $4 billion revenue, the RP-Sanjiv Goenka Group is one of India’s fastest growing conglomerates with a significant global presence. The Group’s businesses include power and energy, carbon black manufacturing, retail, IT-enabled services, FMCG, media and entertainment, and agriculture.
DR RP Goenka has been regarded very highly for his keen business acumen and his expertise in strategic takeovers. But he has stated that he always did his business dealings more with his heart than his mind.
“I HAVE NEVER LOOKED AT THE BALANCE SHEET OF ANY COMPANY I TOOK OVER. IT WAS PURE GUT-FEEL AND I NEVER WENT WRONG. THE MOMENT I IGNORED THE GUT REACTION, I MADE A MISTAKE.”
CMP : 1520 (23.03.2021)
52 WEEKS HIGH/LOW : 1747/ 185 As on 23.03.2021 .
TARGET EXPECTED IN 1 YEAR : 1800 to 2800 .
Time Frame : Short Term – 15 DAYS – 6 MONTHS .
Long Term Target : 4500 – 8400 ++
Time Frame : 2 Years to 5 Years .
BASED ON TECHNICAL CHARTS OR INDICATORS .
As per Technical Charts its Clearly Indicating New 52 Weeks High it Might Crossed in Short Term Itself .
Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
